当前位置：首页 > 文献互助 > 互助详情

其他Ivonescimab in advanced NSCLC: is progression-free survival enough, or are overall survival data also needed?复制

用户7nEFK6amBq5Y 1个月前 57 已完结

1. 系统已在2025-10-28 14:32:17对应助文件进行删除

2. 如有需要请重新发布求助信息

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

其他信息:

互助时间线

楼主确认了jodie0105应助的文件是正确的, 求助状态变成已完结

jodie0105上传了文件(pdf 568.30 KB), 求助状态变成待确认

Structure-guided design of a synthetic bile acid that inhibits Clostridioides difficile TcdB toxin 17分钟前

A focused report on IFN-1 targeted therapies for lupus erythematosus 57分钟前

Solid catalyst component for polymerization of olefins and catalyst 3小时前

Design and Analysis of Phase I Clinical Trials 3小时前

Sudden Loss of Consciousness Following Psilocybin Ingestion 3小时前

Current updates in the epidemiology and comorbidities of atopic dermatitis 4小时前

Designer catalytic nanopores meet PET nanoparticles 5小时前

Interpretable machine learning for knowledge generation in heterogeneous catalysis 5小时前

Recent Progress in Electro- and Photocatalyst Discovery with Machine Learning 5小时前

Machine Learning for Electrocatalyst and Photocatalyst Design and Discovery 5小时前

Boron Delta-Doping in Si : B Stacks By RP-CVD Epitaxy 5小时前